A survival model for the study of myocardial angiogenesis.
Maulik
Nilanjana
N
Cardiovascular Research Center, University of Connecticut School of Medicine, Farmington, Connecticut 06030, USA.
Fukuda
Shoji
S
Sasaki
Hiroaki
H
D000818:Animals; D017209:Apoptosis; D015153:Blotting, Western; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002196:Capillaries / Q000378:metabolism; D004280:Dobutamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D016228:Endothelial Growth Factors / Q000378:metabolism; D004730:Endothelium, Vascular / Q000166:cytology; D006321:Heart / Q000502:physiology*; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D008222:Lymphokines / Q000378:metabolism; D008297:Male; D009203:Myocardial Infarction / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D018919:Neovascularization, Physiologic; D009502:Neutrons; D051381:Rats; D017207:Rats, Sprague-Dawley; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016276:Ventricular Function
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D004280:Dobutamine; D001973:Bromodeoxyuridine